APN-14084-00530
4 vaccinations
10 coded responses
44 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 197 / DE
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Registered in v-safe
-
2021-03-14
Dose 1 — Pfizer-BioNTech
- 2021-03-14
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-28
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Allodynia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: AllodyniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Joint painsFree text: Swollen painful lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Joint painsFree text: Swollen painful lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Joint painsFree text: Mild swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph node, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: PainFree text: Swollen painful axillary lymph node on side where injection was givenMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
-
2021-11-06
Survey response — day 35, dose 3MedDRA: Migraine, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: More frequent migraines. Nausea that lasted 2 days.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Survey response — day 42, dose 3MedDRA: Migraine, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chronic daily nausea. More frequent migraines.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-22
-
2022-01-01
Survey response — 3 months, dose 3MedDRA: Migraine, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: About 6 weeks of daily chronic nausea. Worked up with blood tests and abdominal ultrasound finding nothing of note. Resolved after stopping new migraine med topiramate.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-04
- 2022-04-02
-
2022-09-25
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-02
- 2022-10-02
- 2022-10-09
- 2022-10-18
- 2022-10-23
- 2022-12-25
-
2023-03-28
Survey response — 6 months, dose 4MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-28
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2023-03-29
- 2023-03-29
- 2023-03-29
- 2023-04-21
- 2023-04-21
- 2023-04-21
-
2023-05-09
Callback requested for10:00AM ET
-
2023-05-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-05-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-05-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-25 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
3 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Allodynia
Systemic reaction (other): Swollen painful lymph nodes
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen painful lymph nodes
Systemic reaction (other): Mild swollen lymph nodes
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph node, sore throat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen painful axillary lymph node on side where injection was given
Release 10 — day 35, dose 3
Symptoms: More frequent migraines. Nausea that lasted 2 days.
Release 10 — day 42, dose 3
Symptoms: Chronic daily nausea. More frequent migraines.
Release 10 — 3 months, dose 3
Symptoms: About 6 weeks of daily chronic nausea. Worked up with blood tests and abdominal ultrasound finding nothing of note. Resolved after stopping new migraine med topiramate.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Allodynia | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release